Earnings reports: CAMP4 files. Stoke optimizing. Praxis on track. 2026 Video! #S10e207

Friday, May 8, 2026 - Week 19CURE SYNGAP1 STRATEGY WORKINGOur strategy has always been to derisk SYNGAP1 so that industry will invest and bring their skill and capital to bear.  We leverage donor dollars to maximize impact.  Yesterday was a great example:EARNINGS REPORTSCAMP4 1Q26 Results: $99M https://investors.camp4tx.com/news-releases/news-release-details/camp4-reports-first-quarter-2026-financial-results-and-corporateWe submitted our first regulatory filing for CMP-002 in Australia which positions us to initiate a global first-in-human Phase 1/2 clinical trial in the second half of 2026.Stoke 1Q26 Results: $411M https://investor.stoketherapeutics.com/news-releases/news-release-details/stoke-therapeutics-announces-first-quarter-2026-financial Lead optimization is underway to identify a clinical candidate for the treatment of SYNGAP1 in 2026. SYNGAP1 is a severe and rare genetic neurodevelopmental disease.Praxis 1Q26 Results: $1.4B https://investors.praxismedicines.com/news-releases/news-release-details/praxis-precision-medicines-provides-corporate-update-and-19 Praxis remains on track to nominate a development candidate for each of its three early stage ASO therapeutic initiatives in the first half of 2026:  PRAX-090 is designed to address SYNGAP1 loss-of-function (LoF) mutations, a leading cause of severe intellectual disability and epilepsy in DEEs.#CompetitionIsGoodForThePatientKCNT1 Big Day today - CongratulationsPost: https://www.linkedin.com/posts/graglia_kcnt1-share-7458560855744618496-X10dPress Release: https://www.linkedin.com/posts/kcnt1-kcnt1-epilepsy-ugcPost-7458487179149787136-kH7cWATCH & SHARE OUR VIDEOWatch and share the new SYNGAP1 Video, it is excellent and helps explain our cause to families and friends.  We need to turn them into supporters and donors.cureSYNGAP1.org/SYNGAP1 -> https://youtu.be/pO3ayASBiEkINAUGURAL SF NIGHT OF IMPACT, CA – 20 daysJoin us this is our only Gala for 2026!cureSYNGAP1.org/SF265TH SCRAMBLE FOR SYNGAP, SC – 148 daysClassic case of a small event becoming an institution!cureSYNGAP1.org/Scramble26USA: use your ICD-10, F78.A1: https://onlinelibrary.wiley.com/doi/10.1002/epi.70142PUBMEDPubmed 2026 is at 28. +9 vs the week. (61 last year was +9) https://pubmed.ncbi.nlm.nih.gov/?term=syngap1&filter=years.2026-2026&sort=datehttps://pubmed.ncbi.nlm.nih.gov/42093631/ ADHD in patients with #DLG2 #NRXN1 #SHANK3 #SYNGAP1SOCIAL MATTERS4,940 LinkedIn.  https://www.linkedin.com/company/curesyngap11,569 YouTube.  https://www.youtube.com/@CureSYNGAP111.1k Twitter https://twitter.com/cureSYNGAP145k Insta https://www.instagram.com/curesyngap1$CAMP closed at $4.46. https://www.google.com/finance/beta/quote/CAMP:NASDAQ$STOK closed at $32.89. https://www.google.com/finance/beta/quote/STOK:NASDAQ$ACAD closed at $22.40. https://www.google.com/finance/beta/quote/ACAD:NASDAQ$PRAX closed at $330.02. https://www.google.com/finance/beta/quote/PRAX:NASDAQLike and subscribe to this podcast wherever you listen. https://curesyngap1.org/podcasts/syngap10Episode 207 of #Syngap10 #SYNGAP1 #CureSYNGAP1 #Podcast #PatientAdvocacy